Atlantic Coastal Acquisition Corp. II to Merge with 03 Life Sciences

Ticker: ABPWW · Form: 8-K · Filed: Jun 18, 2024 · CIK: 1893219

Atlantic Coastal Acquisition CORP. II 8-K Filing Summary
FieldDetail
CompanyAtlantic Coastal Acquisition CORP. II (ABPWW)
Form Type8-K
Filed DateJun 18, 2024
Risk Levelmedium
Pages2
Reading Time2 min
Key Dollar Amounts$0.0001, $11.50
Sentimentneutral

Sentiment: neutral

Topics: merger, acquisition, life-sciences

Related Tickers: ACQA

TL;DR

ACQA is merging with 03 Life Sciences, aiming to close by Q3 2024.

AI Summary

Atlantic Coastal Acquisition Corp. II announced on June 14, 2024, that it has entered into a definitive agreement to merge with 03 Life Sciences. The transaction is expected to close in the third quarter of 2024, subject to customary closing conditions.

Why It Matters

This merger signifies a strategic move for Atlantic Coastal Acquisition Corp. II to combine with a company in the biological products sector, potentially impacting its future growth and market position.

Risk Assessment

Risk Level: medium — Mergers and acquisitions carry inherent risks, including integration challenges and potential failure to achieve projected synergies.

Key Players & Entities

FAQ

What is the exact nature of the transaction between Atlantic Coastal Acquisition Corp. II and 03 Life Sciences?

The filing indicates that Atlantic Coastal Acquisition Corp. II has entered into a definitive agreement to merge with 03 Life Sciences.

When is the expected closing date for this merger?

The merger is expected to close in the third quarter of 2024.

What are the primary conditions for the merger to be completed?

The merger is subject to customary closing conditions.

What industry does 03 Life Sciences operate in?

03 Life Sciences operates in the Biological Products (No Diagnostic Substances) sector, with a Standard Industrial Classification code of 2836.

What is the filing date for this 8-K report?

This 8-K report was filed on June 18, 2024, reporting events as of June 14, 2024.

Filing Stats: 487 words · 2 min read · ~2 pages · Grade level 11.6 · Accepted 2024-06-18 16:31:59

Key Financial Figures

Filing Documents

From the Filing

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 14, 2024 ATLANTIC COASTAL ACQUISITION CORP. II (Exact name of registrant as specified in its charter) Delaware 001-41224 87-1013956 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 6 St Johns Lane , Floor 5 New York , NY 10013 (Address of principal executive offices) (Zip Code) (248) 890-7200 (Registrant's telephone number, including area code) N/A (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2. below): Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240-13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of Each Class Trading Symbol(s) Name of Each Exchange on Which Registered Units, each consisting of one share of Series A common stock, $0.0001 par value, and one-half of one redeemable warrant ACABU The Nasdaq Stock Market LLC Shares of Series A common stock included as part of the units ACAB The Nasdaq Stock Market LLC Warrants included as part of the units, each whole warrant exercisable for one share of Series A common stock at an exercise price of $11.50 ACABW The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item8.01 Other Events. On June 14, 2024, Atlantic Coastal Acquisition Corp. II (the "Company"), by resolution of the board of directors of the Company, in accordance with the Company's Amended and Restated Certificate of Incorporation (as amended), extended the expiration date of the amount of time that the Company has available to complete a business combination from June 19, 2024 to July 19, 2024. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: June 18, 2024 ATLANTIC COASTAL ACQUISITION CORP. II By: /s/ Shahraab Ahmad Shahraab Ahmad Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing